Bonus Episode: Predicting the disease course and prognosis in IPF
The publication of this podcast was funded by CSL Behring. The views and opinions expressed are exclusively those of the speakers.
In this section, the panel considers the expert insights of Prof. Wijsenbeek, concerning the challenges of predicting the disease course and prognosis of patients with idiopathic pulmonary fibrosis (IPF). The conversation reflects on current knowledge, real-world practices, treatment options, and tools available to healthcare professionals.